Literature DB >> 28223422

A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.

Lili Li1, Matthew Neil Bainbridge1, Yanli Tan1, James T Willerson1, Ali J Marian2.   

Abstract

RATIONALE: Hypertrophic cardiomyopathy (HCM) is a prototypic single-gene disease caused mainly by mutations in genes encoding sarcomere proteins. Despite the remarkable advances, the causal genes in ≈40% of the HCM cases remain unknown, typically in small families and sporadic cases, wherein cosegregation could not be established.
OBJECTIVE: To test the hypothesis that the missing causal genes in HCM is, in part, because of an oligogenic cause, wherein the pathogenic variants do not cosegregate with the phenotype. METHODS AND
RESULTS: A clinically affected trio with HCM underwent clinical evaluation, electrocardiography, echocardiography, magnetic resonance imaging, and whole exome sequencing. Pathogenic variants in the whole exome sequencing data were identified using established algorithms. Family members were genotyped by Sanger sequencing and cosegregation was analyzed. The siblings had a severe course, whereas the mother had a mild course. Variant analysis showed that the trio shared 145 heterozygous pathogenic variants in 139 genes, including 2 in cardiomyopathy genes TTN and ALPK3. The siblings also had the pathogenic variant p.Ala13Thr variant in MYL2, a known gene for HCM. The sibling's father also carried the p.Ala13Thr variant, in whom an unambiguous diagnosis of HCM could not be made because of concomitant severe aortic stenosis. The TTN variant segregated with HCM, except in a 7-year-old boy, who had a normal phenotype. The ALPK3 variant, shared by the affected trio, did not segregate with the phenotype.
CONCLUSIONS: We posit that a subset of HCM might be oligogenic caused by multiple pathogenic variants that do not perfectly cosegregate with the phenotype.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  bioinformatics; cardiomyopathy; echocardiography; exome; genetic testing; siblings

Mesh:

Substances:

Year:  2017        PMID: 28223422      PMCID: PMC5380229          DOI: 10.1161/CIRCRESAHA.116.310559

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.

Authors:  Barry J Maron; Martin S Maron; Christopher Semsarian
Journal:  Heart Rhythm       Date:  2011-08-09       Impact factor: 6.343

2.  Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling.

Authors:  J Ingles; A Doolan; C Chiu; J Seidman; C Seidman; C Semsarian
Journal:  J Med Genet       Date:  2005-10       Impact factor: 6.318

3.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

4.  A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate.

Authors:  Koustubh Ranade; Eric Jorgenson; Wayne H-H Sheu; Dee Pei; Chao Agnes Hsiung; Fu-tien Chiang; Yii-der I Chen; Richard Pratt; Richard A Olshen; David Curb; David R Cox; David Botstein; Neil Risch
Journal:  Am J Hum Genet       Date:  2002-02-18       Impact factor: 11.025

5.  Molecular findings among patients referred for clinical whole-exome sequencing.

Authors:  Yaping Yang; Donna M Muzny; Fan Xia; Zhiyv Niu; Richard Person; Yan Ding; Patricia Ward; Alicia Braxton; Min Wang; Christian Buhay; Narayanan Veeraraghavan; Alicia Hawes; Theodore Chiang; Magalie Leduc; Joke Beuten; Jing Zhang; Weimin He; Jennifer Scull; Alecia Willis; Megan Landsverk; William J Craigen; Mir Reza Bekheirnia; Asbjorg Stray-Pedersen; Pengfei Liu; Shu Wen; Wendy Alcaraz; Hong Cui; Magdalena Walkiewicz; Jeffrey Reid; Matthew Bainbridge; Ankita Patel; Eric Boerwinkle; Arthur L Beaudet; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng
Journal:  JAMA       Date:  2014-11-12       Impact factor: 56.272

6.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.

Authors:  Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins
Journal:  Genet Med       Date:  2016-08-17       Impact factor: 8.822

7.  Fast and accurate long-read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2010-01-15       Impact factor: 6.937

8.  Truncations of titin causing dilated cardiomyopathy.

Authors:  Daniel S Herman; Lien Lam; Matthew R G Taylor; Libin Wang; Polakit Teekakirikul; Danos Christodoulou; Lauren Conner; Steven R DePalma; Barbara McDonough; Elizabeth Sparks; Debbie Lin Teodorescu; Allison L Cirino; Nicholas R Banner; Dudley J Pennell; Sharon Graw; Marco Merlo; Andrea Di Lenarda; Gianfranco Sinagra; J Martijn Bos; Michael J Ackerman; Richard N Mitchell; Charles E Murry; Neal K Lakdawala; Carolyn Y Ho; Paul J R Barton; Stuart A Cook; Luisa Mestroni; J G Seidman; Christine E Seidman
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

Review 9.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

10.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications.

Authors:  Andy Rimmer; Hang Phan; Iain Mathieson; Zamin Iqbal; Stephen R F Twigg; Andrew O M Wilkie; Gil McVean; Gerton Lunter
Journal:  Nat Genet       Date:  2014-07-13       Impact factor: 38.330

View more
  15 in total

1.  Analysis of selected genes associated with cardiomyopathy by next-generation sequencing.

Authors:  Viktoria Szabadosova; Iveta Boronova; Peter Ferenc; Iveta Tothova; Jarmila Bernasovska; Michaela Zigova; Jan Kmec; Ivan Bernasovsky
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

Review 2.  Genetic Testing in Cardiovascular Medicine.

Authors:  Ali J Marian
Journal:  Tex Heart Inst J       Date:  2018-08-01

Review 3.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Multiallelic rare variants support an oligogenic origin of sudden cardiac death in the young.

Authors:  Hager Jaouadi; Yosra Bouyacoub; Sonia Chabrak; Lilia Kraoua; Amira Zaroui; Sahar Elouej; Majdi Nagara; Hamza Dallali; Valérie Delague; Nicolas Levy; Rym Benkhalifa; Rachid Mechmeche; Stéphane Zaffran; Sonia Abdelhak
Journal:  Herz       Date:  2020-01-22       Impact factor: 1.443

5.  Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction.

Authors:  Karol Miszalski-Jamka; John L Jefferies; Wojciech Mazur; Jan Głowacki; Jianhong Hu; Monika Lazar; Richard A Gibbs; Jacek Liczko; Jan Kłyś; Eric Venner; Donna M Muzny; Jarosław Rycaj; Jacek Białkowski; Ewa Kluczewska; Zbigniew Kalarus; Shalini Jhangiani; Hussein Al-Khalidi; Tomasz Kukulski; James R Lupski; William J Craigen; Matthew N Bainbridge
Journal:  Circ Cardiovasc Genet       Date:  2017-08

Review 6.  From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies.

Authors:  Nosheen Reza; Kiran Musunuru; Anjali Tiku Owens
Journal:  Curr Heart Fail Rep       Date:  2019-10

7.  Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.

Authors:  Kai Chen; Jiangping Song; Zhen Wang; Man Rao; Liang Chen; Shengshou Hu
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

8.  Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.

Authors:  Ali J Marian; Yanli Tan; Lili Li; Jeffrey Chang; Petros Syrris; Manouchehr Hessabi; Mohammad H Rahbar; James T Willerson; Benjamin Y Cheong; Chia-Ying Liu; Neal S Kleiman; David A Bluemke; Sherif F Nagueh
Journal:  Circ Res       Date:  2018-03-14       Impact factor: 17.367

9.  Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees.

Authors:  Jason R Cowan; Daniel D Kinnamon; Ana Morales; Lorien Salyer; Deborah A Nickerson; Ray E Hershberger
Journal:  Circ Genom Precis Med       Date:  2018-07

Review 10.  Myofibrillar myopathy in the genomic context.

Authors:  Jakub Piotr Fichna; Aleksandra Maruszak; Cezary Żekanowski
Journal:  J Appl Genet       Date:  2018-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.